Regular Hours
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-19.00/-0.86
|
|
Enterprise Value
51.23M
|
| Balance Sheet |
|
Book Value Per Share
-0.87
|
| Cash Flow |
|
Cash Flow Yield
--
|
| Income Statement |
|
Total Revenue
0
|
|
Operating Revenue Per Share
0.58
|
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
|
Business Description
|
|||
| NovaBay Pharmaceuticals Inc is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, it seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight. |

1.945 
